author-photo

Olle Larsson

Karolinska University Hospital

119

Papers

5892

Citations

Citation Trend

Filter By

Papers (82) Sort By

Journal Conference Others

TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma.

2021 Modern Pathology
Show All
- Source
- Cite
- Save
Citations (1)
Transcriptome profiling of Ewing sarcomas – treatment resistance pathways and IGF‐dependency

2020 Molecular Oncology
Show All
- Source
- Cite
- Save
Citations (3)
RUNNING DATABASES IN A KUBERNETES CLUSTERAn evaluation

2019
- Olle Larsson
Show All
- Source
- Cite
- Save
Citations (0)
Telomerase promoter mutations and copy number alterations in solitary fibrous tumours

2018 Journal of Clinical Pathology
Show All
- Source
- Cite
- Save
Citations (7)
Phase I clinical trial of AXL1717 for treatment of relapsed malignant astrocytomas: analysis of dose and response

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (21)
A novel targeted oral insulin-like growth factor-1 receptor (IGF-1R) inhibitor and its implications for patients with non-small cell lung cancer (NSCLC): A phase I clinical trial.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Nuclearly translocated insulin-like growth factor 1 receptor phosphorylates histone H3 at tyrosine 41 and induces SNAI2 expression via Brg1 chromatin remodeling protein.

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (23)
A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial

2016 Acta Oncologica
Show All
- Source
- Cite
- Save
Citations (12)
Microenvironmental Targets in Sarcoma

2015 Frontiers in Oncology
- Monika Ehnman
- Olle Larsson
Show All
- Source
- Cite
- Save
Citations (17)
Nuclear translocation of IGF-1R via p150 Glued and an importin-β/RanBP2-dependent pathway in cancer cells

2015 Oncogene
Show All
- Source
- Cite
- Save
Citations (37)